Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Le Large TYS"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.
Autorzy:
Mato Prado M; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.; UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.
Puik JR; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Castellano L; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.; School of Life Sciences, University of Sussex, John Maynard Smith Building, Falmer, Brighton, BN1 9QG, UK.
López-Jiménez E; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.
Liu DSK; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.
Meijer LL; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Le Large TYS; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Rees E; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.
Funel N; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Sivakumar S; Oncology Department and Institute of Immunology and Immunotherapy, Birmingham Medical School, University of Birmingham, Birmingham, B15 2TT, UK.
Pereira SP; Institute for Liver & Digestive Health, Royal Free Hospital Campus, University College London, London, UK.
Kazemier G; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Zonderhuis BM; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Erdmann JI; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Swijnenburg RJ; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Frilling A; HPB Surgical Unit, Department of Surgery & Cancer, Imperial College London, London, UK.
Jiao LR; HPB Surgical Unit, Department of Surgery & Cancer, Imperial College London, London, UK.
Stebbing J; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.; Department of Biomedical Sciences, Anglia Ruskin University, Cambridge, UK.
Giovannetti E; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. .; Cancer Pharmacology Lab, Fondazione Pisana per la Scienza, Pisa, Italy. .
Krell J; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK. .
Frampton AE; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK. .; HPB Surgical Unit, Department of Surgery & Cancer, Imperial College London, London, UK. .; HPB Surgical Unit, Royal Surrey NHS Foundation Trust, Guildford, Surrey, UK. .; Section of Oncology, Dept. of Clinical & Experimental Medicine, FHMS, University of Surrey, Guildford, UK. .
Pokaż więcej
Źródło:
Experimental hematology & oncology [Exp Hematol Oncol] 2023 Dec 01; Vol. 12 (1), pp. 101. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Letter
Opinia redakcyjna
Tytuł:
Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits.
Autorzy:
Rodriguez E; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
Boelaars K; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
Brown K; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
Madunić K; Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.
van Ee T; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
Dijk F; Amsterdam UMC, Academic Medical Center Amsterdam, University of Amsterdam, Department of Pathology, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Verheij J; Amsterdam UMC, Academic Medical Center Amsterdam, University of Amsterdam, Department of Pathology, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Li RJE; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
Schetters STT; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
Meijer LL; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Le Large TYS; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Driehuis E; Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, The Netherlands.
Clevers H; Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, The Netherlands.
Bruijns SCM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
O'Toole T; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
van Vliet SJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
Bijlsma MF; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.; Oncode Institute, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.
Kazemier G; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Giovannetti E; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza, Pisa, Italy.
Garcia-Vallejo JJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.
van Kooyk Y; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Jan 11; Vol. 5 (1), pp. 41. Date of Electronic Publication: 2022 Jan 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/immunology
Carcinoma, Pancreatic Ductal*/metabolism
Carcinoma, Pancreatic Ductal*/pathology
Glycoproteins*/chemistry
Glycoproteins*/genetics
Glycoproteins*/immunology
Glycoproteins*/metabolism
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/immunology
Pancreatic Neoplasms*/metabolism
Pancreatic Neoplasms*/pathology
Epithelial-Mesenchymal Transition/genetics ; Epithelial-Mesenchymal Transition/immunology ; Glycosylation ; Humans ; Pancreas/metabolism ; Pancreas/pathology ; Polysaccharides/chemistry ; Polysaccharides/genetics ; Polysaccharides/immunology ; Polysaccharides/metabolism
Czasopismo naukowe
Tytuł:
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach.
Autorzy:
Boyd LNC; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Lab of Medical Oncology, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Ali M; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Kam L; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Puik JR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Lab of Medical Oncology, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Rodrigues SMF; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Lab of Medical Oncology, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Zwart ES; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Daams F; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Zonderhuis BM; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Meijer LL; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Lab of Medical Oncology, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Department of Surgery, Erasmus MC-University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Le Large TYS; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Lab of Medical Oncology, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Department of Surgery, Dijklander Ziekenhuis Locatie Hoorn, Maelsonstraat 3, 1624 NP Hoorn, The Netherlands.
Giovannetti E; Lab of Medical Oncology, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza, Via Ferruccio Giovannini 13, San Giuliano Terme PI, 56017 Pisa, Italy.
van Laarhoven HWM; Lab of Medical Oncology, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Kazemier G; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1118, 1081 HZ, Postbus 7057, 1007 MB Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Jan 11; Vol. 14 (2). Date of Electronic Publication: 2022 Jan 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma.
Autorzy:
Le Large TYS; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.; Laboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Bijlsma MF; Laboratory for Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Oncode Institute, Amsterdam, The Netherlands.
El Hassouni B; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Mantini G; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.; Cancer Pharmacology Lab, AIRC-Start-Up, Fondazione Pisana per la Scienza, Pisa, Italy.
Lagerweij T; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.; Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University Amsterdam, Amsterdam, The Netherlands.
Henneman AA; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Funel N; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Kok B; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Pham TV; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
de Haas R; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Morelli L; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Knol JC; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Piersma SR; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
Kazemier G; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University Amsterdam, Amsterdam, The Netherlands.
van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Giovannetti E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. .; Cancer Pharmacology Lab, AIRC-Start-Up, Fondazione Pisana per la Scienza, Pisa, Italy. .
Jimenez CR; OncoProteomics Laboratory, Department of Medical Oncology, Cancer, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Mar 09; Vol. 40 (1), pp. 91. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma/*drug therapy
Antineoplastic Agents, Phytogenic/*therapeutic use
Carcinoma, Pancreatic Ductal/*drug therapy
Focal Adhesion Protein-Tyrosine Kinases/*metabolism
Paclitaxel/*therapeutic use
Animals ; Antineoplastic Agents, Phytogenic/pharmacology ; Carcinoma, Pancreatic Ductal/pathology ; Cell Line, Tumor ; Humans ; Mice ; Paclitaxel/pharmacology ; Phosphorylation ; Signal Transduction
Czasopismo naukowe
Tytuł:
Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas.
Autorzy:
Mantini G; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.; Fondazione Pisana per la Scienza, 56017 Pisa, Italy.
Meijer LL; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Glogovitis I; Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.; Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4002 Plovdiv, Bulgaria.
In 't Veld SGJG; Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Paleckyte R; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Capula M; Fondazione Pisana per la Scienza, 56017 Pisa, Italy.; Institute of Life Sciences, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy.
Le Large TYS; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Morelli L; General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Pham TV; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Piersma SR; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Frampton AE; Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, The Leggett Building, University of Surrey, Guildford GU2 7WG, UK.; Faculty of Health and Medical Sciences, The Leggett Building, University of Surrey, Guildford GU2 7XH, UK.
Jimenez CR; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Kazemier G; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Koppers-Lalic D; Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Wurdinger T; Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Giovannetti E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.; Fondazione Pisana per la Scienza, 56017 Pisa, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Dec 29; Vol. 13 (1). Date of Electronic Publication: 2020 Dec 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers.
Autorzy:
Mantini G; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Fondazione Pisana Per La Scienza, Pisa, Italy.
Vallés AM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Le Large TYS; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Univ of Amsterdam, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, The Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, The Netherlands.
Capula M; Fondazione Pisana Per La Scienza, Pisa, Italy.
Funel N; U.O. Anatomia ed Istologia Patologica II Azienda Ospedaliero Universitaria Pisana , Pisa, Italy.
Pham TV; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Piersma SR; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Kazemier G; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, The Netherlands.
Bijlsma MF; U.O. Anatomia ed Istologia Patologica II Azienda Ospedaliero Universitaria Pisana , Pisa, Italy.; Oncode Institute, Amsterdam, The Netherlands.
Giovannetti E; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands. .; Fondazione Pisana Per La Scienza, Pisa, Italy. .
Jimenez CR; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2020 Dec; Vol. 43 (6), pp. 1147-1159. Date of Electronic Publication: 2020 Aug 29.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*genetics
Pancreatic Neoplasms/*genetics
Proteome/*metabolism
Adenocarcinoma/genetics ; Biomarkers, Tumor/metabolism ; Carcinoma, Pancreatic Ductal/genetics ; Gene Regulatory Networks ; Humans ; Multivariate Analysis ; Neoplasm Proteins/metabolism ; Prognosis ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors.
Autorzy:
Meijer LL; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.
Puik JR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.
Le Large TYS; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.; Laboratory of Experimental Oncology and Radiobiology, Amsterdam UMC, University of Amsterdam, 1105 AZ, The Netherlands.
Heger M; Department of Experimental Surgery, Amsterdam UMC, University of Amsterdam, 1105 AZ, The Netherlands.; Department of Pharmaceutics, Jiaxing University Medical College, Jiaxing 314001, Zhejiang, China.; Department of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, 3584 CG, The Netherlands.
Dijk F; Department of Pathology, Amsterdam UMC, University of Amsterdam, 1105 AZ, The Netherlands.
Funel N; Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza onlus, 56017 Pisa, Italy.
Wurdinger T; Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.
Garajová I; Medical Oncology Unit, University Hospital of Parma, 43 126 Parma, Italy.
van Grieken NCT; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.
van de Wiel MA; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.
Giovannetti E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands. .; Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza onlus, 56017 Pisa, Italy. .
Kazemier G; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, 1081 HV, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2019 Aug 15; Vol. 11 (8). Date of Electronic Publication: 2019 Aug 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies